Faculty, Staff and Student Publications

Authors

    Language

    English

    Publication Date

    6-1-2022

    Journal

    Cancer Immunology, Immunotherapy

    DOI

    10.1007/s00262-021-03084-2

    PMID

    34716463

    PMCID

    PMC10992051

    PubMedCentral® Posted Date

    10-30-2021

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    An important mechanism of oncolytic virotherapy in ameliorating cancer immunotherapy is by inducing significant changes in the immune landscape in the tumor microenvironment (TME). Despite this notion and the potential therapeutic implications, a comprehensive analysis of the immune changes in carcinomas induced by virotherapy has not yet been elucidated. We conducted single-cell RNA sequencing analysis on carcinomas treated with an HSV-2-based oncolytic virus to characterize the immunogenic changes in the TME. We specifically analyzed and compared the immune cell composition between viral treated and untreated tumors. We also applied CellChat to analyze the complex interactions among the infiltrated immune cells. Our data revealed significant infiltration of B cells in addition to other important immune cells, including CD4

    Keywords

    Carcinoma, Humans, Immunotherapy, Oncolytic Virotherapy, Oncolytic Viruses, Sequence Analysis, RNA, Tumor Microenvironment, Single-cell RNA sequencing, Virotherapy, Oncolytic herpes simplex virus, Immune landscape, Tumor microenvironment

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.